Without real lifestyle changes, most people regain the weight, sometimes more than they lost
The launch of our GLP-1 weight management solution is the latest example of our commitment to helping our employer clients with improved utilization of these drugs through better management of medication costs while ensuring members receive high-value, appropriate care, said Dayne Williams, CEO of Quantum Health
IMPLICATIONS FOR TREATMENT The research underscores the importance of assessing weight history in addition to current weight in patients with eating disorders and shows that drugs that affect GLP-1 receptor agonists, initially approved by the FDA for type 2 diabetes and, more recently, for weight loss, could have potential applications in managing binge eating
You can also use the chat feature on this page to find out if you qualify today
It didn't look like it used to